Log inSign up
JAMA
51.1K posts
JAMA profile banner
@JAMA_current

JAMA

@JAMA_current
JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.
Chicago, IL
jama.com
Joined May 2009
435
Following
495K
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @JAMA_current
    JAMA
    @JAMA_current
    7h
    🧵 From breakthrough studies in #AFib and #myocardial infarction to advances in #AI, #cardiac amyloidosis, and preventive #cardiology, explore the latest research presented by JAMA at #ESCCongress: 1️⃣ In patients with myocardial scar on cardiovascular magnetic resonance and left
    Image
    Image
    2
  • @JAMA_current
    JAMA
    @JAMA_current
    8h
    🎙️ In this special #ESCCongress edition of the JAMA Editor's Summary podcast, JAMA Executive Editor Greg Curfman, MD, is joined by JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editors Gregg C. Fonarow, MD, and Paz Tayal, BMBCh, PhD, to discuss: ➡️ Digital
    Image
  • @JAMA_current
    JAMA
    @JAMA_current
    10h
    🧵 Presented today at #ESCCongress from @JAMACardio: In a multicenter cohort of patients with newly diagnosed #TransthyretinCardiacAmyloidosis, increasing #TricuspidRegurgitation severity by vena contracta width, effective regurgitant orifice area, and regurgitant volume was
    Image
    2
  • @JAMA_current
    JAMA
    @JAMA_current
    13h
    🧵 Presented today at #ESCCongress from @JAMACardio: In a multicenter cohort of patients with newly diagnosed #TransthyretinCardiacAmyloidosis, increasing #TricuspidRegurgitation severity by vena contracta width, effective regurgitant orifice area, and regurgitant volume was
    Image
    2
  • @JAMA_current
    JAMA
    @JAMA_current
    Aug 30
    Presented at #ESCCongress: Among patients aged 65 to 80 years undergoing #TranscatheterAorticValveImplant for severe aortic valve stenosis, monotherapy with a factor Xa inhibitor non-vitamin K antagonist oral anticoagulant reduced hypoattenuated leaflet thickening on
    Image
    1
Advertisement
Advertisement